Coverage from the 64th Scientific Sessions of the American College of Cardiology.
Maintaining weight loss offers many health benefits, and a study presented on March 16, 2015, at the 64th Annual Meeting of the American College of Cardiology added another item to the list: obese patients with atrial fibrillation are far more likely to rid themselves of this heart ailment if they shed pounds.
For obese patients, weight loss might require support, as researchers of the LEGACY (Long-Term Effect of Goal-Directed Weight Management on an Atrial Fibrillation Cohort) study concluded. Support is worth providing, because the study found that if patients lost at least 10% of their body weight, they were 6 times more likely to achieve arrhythmiafree survival.
The study, led by Rajeev Pathak, MD, a cardiologist and fellow in electrophysi-ology at the University of Adelaide, Aus-tralia, was the first study to outline the benefits of sustained weight loss, the ef-fects of the amount of weight lost, and the impact of changes in weight over time among patients who suffered from atrial fibrillation (AF). This condition causes shortness of breath and muscle weakness, and can indicate stroke risk. Treatment typically includes anticoagulants, which can present their own risks in some patients.
“We found that sustained weight loss is achievable in obese patients and that it can significantly reduce the burden of atrial fibrillation,” Pathak said. Previous studies had examined only the short-term effects of weight loss on AF.
LEGACY researchers enrolled 355 par-ticipants in a weight loss clinic that pro-vided support through 3 in-person visits a month, nutrition guidance, exercise, counseling and a physical activity diary. All participants were obese (with a body mass index of at least 27 kg/m2) and had AF at the start of the study, and all agreed to participate, which Pathak ac-knowledged does pose some limitations to the results. Subjects with permanent AF, previous AF ablation, and severe medical illnesses were excluded.
Each year for 4 years, participants re-ported for a health exam and an assessment of their AF symptoms, based on their own reports and 7 days’ worth of readings from a Holter monitor. Patients also underwent an echocardiogram and sonogram to measure heart health.
As subjects progressed, they were categorized based on the percentage of body weight lost. Researchers also tracked patients’ AF symptoms, and the results showed that the burden of the condition decreased far more for those who lost the most weight, with both weight loss and weight fluctuation being independent predictors of outcomes. At the 4-year mark, 45% of patients who lost at least 10% of their weight, and 22% of those who lost 3% to 9% of the weight, were free of AF symptoms—without the need for surgery or medication. By con-trast, only 13% of patients who lost less than 3% of their weight were symptom-free without such treatments.
Both sustained weight management and an absence of weight fluctuation were associated with an absence of AF symptoms. Those who lost and regained more than 5% of weight between annu-al visits were twice as likely to experience symptoms. Stable weight loss also helped patients achieve improved blood pressure, cholesterol, and blood sugar levels.
Reference
Pathak R, et al. Long-term effect of goal directed weight management in an atrial fibrillation cohort: A long-term follow-up study (LEGACY Study). J Am Coll Cardiol. doi:101016/jacc.2015.03.002.
Medication Adherence Star Ratings Measures, Health Care Resource Utilization, and Cost
May 9th 2024For patients prescribed diabetes, hypertension, and hyperlipidemia medications, nonadherence to CMS Star Ratings quality measures of medication adherence was associated with increased health care resource utilization and costs.
Read More
Traditional Medicare Supplemental Insurance and the Rise of Medicare Advantage
May 7th 2024Rising Medicare Advantage enrollment occurred alongside declines in enrollment in traditional Medicare with employer-sponsored supplemental coverage and traditional Medicare without supplemental coverage.
Read More
Access Denied: CMS’ Action Hurts Patients With Cancer in Rural America
May 6th 2024CMS rules hindered the access of rural patients with cancer to medically integrated pharmacies in 2023. The authors discuss the impact on equity in health care, emphasizing the need for regulatory change.
Read More